Match tier
Listed
Presence
Current · Arkansas
Last published
2026
Sources
OpenAlex · ORCID
Refreshed
2026-10-09
S
Shivangi Shrimali
Role not yet determined Is this you? Add your title
Also affiliated: United States Food and Drug Administration (2025–2026)
3 h-index
7 pubs
39 cited
Research Areas
Biomedical Subjects
Links
Biography and Research Information
OverviewAI-generated summary
Shivangi Shrimali's research focuses on developing and evaluating new methodologies for assessing drug safety and toxicity, particularly in the context of drug-induced liver injury (DILI). She investigates the application of microphysiological systems (MPS) and other New Approach Methodologies (NAMs) as alternatives to traditional animal testing. Her work aims to integrate in vitro and in silico approaches to improve the prediction of adverse drug reactions. Shrimali has also explored the radioprotective effects of tocotrienols and the development of novel analogues for radiomitigation. Her recent publications address topics such as microRNA expression changes following exposure to specific products and the exploration of sex differences in cardiac intensive care unit admissions. She has a h-index of 3 with 7 total publications and 38 total citations.
Metrics
- h-index: 3
- Publications: 7
- Citations: 39
Selected Publications
-
Exploring Sex Differences in Cardiac ICU Admission and Length of Stay Using Multiple Correspondence Analysis (2026)
-
Integrating in vitro and in silico NAMs for enhanced prediction of drug-induced liver injury (2026)
-
Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells (2026)
-
Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity (2025)
-
New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now? (2025)
-
Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects (2023)
-
466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator (2023)
Collaboration Network
Top Collaborators
Weida Tong
National Center for Toxicological Research
3 shared publications
In database
- New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?
- Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity
- Integrating in vitro and in silico NAMs for enhanced prediction of drug-induced liver injury
Shraddha Thakkar
University of Arkansas for Medical Sciences (US)
2 shared publications
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Darin E. Jones
University of Arkansas for Medical Sciences
2 shared publications
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Nükhet Aykin‐Burns
University of Arkansas for Medical Sciences
2 shared publications
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Philip J. Breen
University of Arkansas for Medical Sciences
2 shared publications
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
César M. Compadre
University of Arkansas for Medical Sciences
2 shared publications
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Dongying Li
National Center for Toxicological Research
2 shared publications
In database
- New approach methodologies (NAMs) for drug-induced liver injury (DILI): Where are we now?
- Microphysiological systems as an emerging in vitro approach for the evaluation of drug absorption, distribution, metabolism, and excretion and toxicity
Beverly Lyn-Cook
National Center for Toxicological Research
2 shared publications
In database
- Exposure to a Titanium Dioxide Product Alters MicroRNA Expression in Human Cells
- Exploring Sex Differences in Cardiac ICU Admission and Length of Stay Using Multiple Correspondence Analysis
Awantika Singh
University of Arkansas for Medical Sciences (US)
1 shared publication
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Rajeshkumar Manian
1 shared publication
- 466 Development of a novel tocotrienol analogue, tocoflexol, as a radiomitigator
Stephen Shrum
University of Arkansas for Medical Sciences
1 shared publication
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Ujwani Nukala
University of Arkansas at Little Rock (US)
1 shared publication
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Edith Nathalie Pineda
University of Arkansas at Little Rock
1 shared publication
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Kimberly J. Krager
University of Arkansas for Medical Sciences
1 shared publication
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Rupak Pathak
University of Arkansas for Medical Sciences
1 shared publication
In database
- Tocotrienols Provide Radioprotection to Multiple Organ Systems through Complementary Mechanisms of Antioxidant and Signaling Effects
Similar Researchers
Based on overlapping research topics
Richard D. Beger
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Biomarkers
Daniel R. Doerge
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Phytochemicals and Antioxidant Activities
Linh‐Chi Ho
Arkansas State University
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Phytochemicals and Antioxidant Activities
Katy S Papineau
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Biomarkers
Xuan Zhang
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Phytochemicals and Antioxidant Activities
Jinchun Sun
National Center for Toxicological Research
Pharmacological Effects and Toxicity Studies
Drug-Induced Hepatotoxicity and Protection
Biomarkers